Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.75 USD | +1.74% | +8.02% | -5.02% |
Apr. 19 | Xenon Pharmaceuticals Inc. Announces Board Resignations | CI |
Mar. 11 | Transcript : Xenon Pharmaceuticals Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-11-2024 11:20 AM |
Financials (USD)
Sales 2024 * | 2.39M | Sales 2025 * | 9.5M | Capitalization | 3.3B |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -260M | EV / Sales 2024 * | 1,146 x |
Net cash position 2024 * | 560M | Net cash position 2025 * | 507M | EV / Sales 2025 * | 294 x |
P/E ratio 2024 * |
-14.8
x | P/E ratio 2025 * |
-13.1
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.16% |
Latest transcript on Xenon Pharmaceuticals Inc.
1 day | +1.74% | ||
1 week | +8.02% | ||
Current month | +7.63% | ||
1 month | +3.55% | ||
3 months | -5.69% | ||
6 months | +33.06% | ||
Current year | -5.02% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Simon Pimstone
FOU | Founder | 56 | 96-11-04 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 20-11-04 |
Mohammad Azab
BRD | Director/Board Member | 68 | 03-09-30 |
Justin Gover
BRD | Director/Board Member | 53 | 23-08-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 16 M€ | -4.51% | ||
0.22% | 0 M€ | 0.00% | - | |
0.22% | 0 M€ | 0.00% | - | |
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 43.75 | +1.74% | 252,216 |
24-05-02 | 43 | +1.20% | 204,121 |
24-05-01 | 42.49 | +4.53% | 368,985 |
24-04-30 | 40.65 | -4.87% | 595,929 |
24-04-29 | 42.73 | +5.51% | 629,045 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.02% | 3.3B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- XENE Stock